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Abstract
Breast carcinoma cells have a specific pattern of expression for Eph receptors and ephrin ligands. EphB6 has previously been
characterized as a signature molecule for invasive breast carcinoma cells. The transcription of EphB6 is silenced in breast
carcinoma cells and its re-expression leads to decreased invasiveness of MDA-MB-231 cells. Such differences in phenotypes
of native and EphB6 expressing MDA-MB-231 cells relate to an altered profile of micro RNAs. Comparative hybridization of
total RNA to slides containing all known miRNAs by using locked nucleic acid (LNA) miRCURY platform yielded a
significantly altered profile of miRNAs in MDA-MB-231 cells stably transfected with EphB6. After applying a threshold of
change and a p-value of ,0.001, the list of significantly altered miRNAs included miR-16, miR-23a, miR-24, miR-26a, miR-29a,
miR-100, miRPlus-E1172 and miRPlus-E1258. The array-based changes were validated by real-time qPCR of miR-16, miR-23a,
miR-24 and miR-100. Except miRPlus-E1172 and miRPlus-E1258, the remaining six miRNAs have been observed in a variety
of cancers. The biological relevance of target mRNAs was predicted by using a common-target selection approach that
allowed the identification of SMARCA5, SMARCC1, eIF2C2, eIF2C4, eIF4EBP2, FKABP5, FKBP1A, TRIB1, TRIB2, TRIB3, BMPR2,
BMPR1A and BMPR1B as important targets of a subset of significantly altered miRNAs. Quantitative PCR revealed that the
levels of SMARCC1, eIFC4, eIF4EB2, FKBP1a, FKBP5, TRIB1, TRIB3, BMPR1a and BMPR2 transcripts were significantly
decreased in MDA-MB-231 cells transfected with EphB6. These observations confirm targeting of specific mRNAs by miR-
100, miR-23a, miR-16 and miR-24, and suggest that the kinase-deficient EphB6 receptor is capable of initiating signal
transduction from the cell surface to the nucleus resulting in the altered expression of a variety of genes involved in
tumorigenesis and invasion. The alterations in miRNAs and their target mRNAs also suggest indirect involvement of EphB6
in PI3K/Akt/mTOR pathways.
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Introduction
Eph receptors belong to the largest class of receptor tyrosine
kinases that are involved in a variety of processes such as hindbrain
patterning, axon guidance and angiogenesis [1]. These molecules
have also been implicated in several cancers, and considerable
work has been done to understand their biological significance in
tumorigenesis [2]. In addition to alterations in several Eph
receptors and ephrin ligands, the expression of EphB6 receptor is
transcriptionally silenced in invasive breast carcinoma cells [3].
The transcriptional silencing of EphB6 is attributed to the
methylation of specific CpG dinucleotides in the gene promoter
[4]. While the transcription of EphB6 gene is not detectable in
MDA-MB-231 cells, transfection of an EphB6 expression
construct significantly reduces in vitro invasiveness of these cells
[5]. Yeast two-hybrid system has indicated possible interaction of
EphB6 with a variety of intracellular proteins [6] that likely
mediate phenotypes of EphB6-expressing cells. Comparative
proteomic analysis of MDA-MB-231 cells have revealed that
EphB6 either directly or indirectly affects the expression of a
variety of proteins that are involved in metabolism, signal
transduction, cytoskeleton and energy homeostasis [7].
The proteomic alterations observed in EphB6 expressing breast
carcinoma cells [7] suggest that changes in the levels of some
proteins may be direct effects of EphB6. However, a majority of
the changes in protein levels appear to be indirect effects of
EphB6. The underlying mechanisms for these changes could
possibly include alterations in the abundance, stability and
translatability of specific transcripts. Among a variety of regulatory
molecules that control the expression of genes encoded in the
human genome, miRNAs have emerged as a very important class
of regulators. These 21 to 23 nucleotide long small molecules
either enhance RNA degradation or prevent translation, and thus
lead to changes in transcript levels as well as proteins [8]. It is
predicted that greater than 2/3
rd of genes encoded in the human
genome have sequences that may be targeted by a variety of
miRNAs. The disease relevance of miRNAs is evident from the
altered levels of these molecules in various cancers [9,10]. The
introduction of a specific miRNA construct in tumor cells has been
shown to suppress tumor phenotypes [11], thus attributing an
important regulatory role to miRNAs. Given the large numbers of
predicted targets for specific miRNAs, a single miRNA can
influence the abundance of a large number of mRNAs and
proteins [12].
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22484Based on the altered proteomic profile of EphB6-transfected
MDA-MB-231 cells [7] it is hypothesized that EphB6 transfection
likely influences protein profile by modulating the abundance of
miRNA complement of the cell. To address this possibility and
establish a relationship between cellular phenotype and miRNAs,
an array-based hybridization strategy was carried out using the
locked nucleic acid (LNA) miRCURY platform. We present here
the relationship between miRNAs and EphB6 expression status of
MDA-MB-231 cells and the biological relevance of these changes
for cancer cell phenotypes.
Results
Quality of RNA used for hybridizations
The yield of total RNA from different samples, as determined
by their absorbance at 260 nm, varied between 50 and 70 mg, and
the ratios of absorbance at 260 nm and 280 nm for various
samples ranged between 2.01 and 2.05. The ratios of 28S and 18S
rRNAs in total RNA preparations made from vector-transfected
and EphB6-transfected clones varied between 1.8 and 1.9, thus
confirming that the samples have not undergone any detectable
degradation. The electropherogram revealed RNA integrity
numbers for various samples ranging between 9.7 and 9.8. These
results indicated the RNAs to be of high quality and well-suited for
performing miRNA profiles.
EphB6 transfection leads to changes in miRNA profiles
The hybridization of total RNA isolated from vector-transfected
and EphB6-transfected MDA-MB-231 cells to miRNA arrays
revealed detectable expression of a large number of miRNAs, as
indicated by significantly higher signal intensities at spots
corresponding to these miRNAs on the slides as compared to
the background. These signal intensities were subsequently
compared to determine a subset of miRNAs that were differen-
tially expressed in EphB6-transfected MDA-MB-231 cells. The
heatmap and alterations in the levels of specific subsets of miRNAs
at different p-values are described in the following sections.
Two-way hierarchical clustering of the data allowed the
construction of the heatmap shown in Figure 1. Since a common
reference pool was used for hybridization, comparisons of samples
Figure 1. Heatmap of altered miRNAs in EphB6-transfected MDA-MB-231 cells. A two-way hierarchical clustering was performed to
generate the heatmap. Each row represents a miRNA and each column represents a sample, and the miRNA clustering tree is shown on the left. Red
color represents an expression level above mean and blue color represents expression level lower than the mean. Top 50 miRNAs altered, based on
variation across replicates, with a p-value of ,0.001 for three vector-transfectants and three EphB6 transfectants are shown.
doi:10.1371/journal.pone.0022484.g001
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intensities at individual spots on the array were recorded as
log2(Hy3/Hy5) values, where Hy3 is sample fluorescence and Hy5
is fluorescence contributed by the common reference pool [13].
Top 50 candidate miRNAs, based on variations across samples,
are represented in the heatmap. It is evident from Figure 1 that 33
miRNAs were upregulated and the levels of 17 miRNAs had
decreased in EphB6-transfected cells as compared to the empty
vector-transfected MDA-MB-231 controls. These miRNAs were
subsequently categorized in two smaller subsets based on p-values
as described below.
The data were analyzed by applying a two-tailed t-test between
the two sample groups of RNAs isolated from vector-transfected
and EphB6-transfected MDA-MB-231 cells, respectively. The
miRNAs that showed alterations with a p-value of less than 0.001
are shown in Table 1. There are 34 miRNAs that satisfied the p-
value cut off. Among the significantly altered miRNAs, 20 miRNAs
were up-regulated while 14 miRNAS are down-regulated.
The array data were filtered by applying absolute D
LogMedianRatios (dLMR), and the results are shown as a
Volcano plot (Figure 2A). These analyses revealed significant
alterations in 8 miRNAs comprising of miR-26a, miRPlus-E1172,
miR-100, miR-23a, miR-16, miR-29a, miR-24 and miRPlus-
E1258 that were altered with a p-value of less than 0.001 and
dLMR either greater than 0.5 or less than 20.5. Among these
miRNAs, seven were up-regulated and miRPlus-1258 was
significantly down-regulated in EphB6 transfected cells. The
differences in the above miRNAs were further confirmed by
plotting the dLMR with standard deviations. The standard
deviations for triplicate measurements of vector-transfected and
EphB6-transfected samples were well within the acceptable range
(Figure 2B). A coordinated expression pattern was observed for
members of two polycistronic miRNA clusters containing miR-
23a, miR-23b, miR-24 and miR-27. The levels of miR-23a, miR-
23b and miR-24 were comparable in all vector-transfected MDA-
MB-231 clones. However, their levels in EphB6-transfected clones
were significantly higher than the vector-transfected clones.
Similar changes were observed in the levels of miR-27 between
vector-transfected and EphB6-transfected clones (Figure 3).
Real-time qPCR validation of specific miRNAs
Of the eight significantly altered miRNAs, miR-100, miR-23a,
miR-16 and miR-24 were validated by qPCR. The comparison of
results from array hybridization and qPCR is shown in Figure 4.
The qPCR fold-changes in the levels of these miRNAs in EphB6-
transfected cells ranged between 1.3 and 1.55. It warrants mention
that array results indicated changes of 1.4 to 1.55 fold in the levels
of these miRNAs in EphB6-transfected cells. Quantitation by
qPCR revealed that the levels of miR-16 and miR-24 in EphB6-
transfected cells were upregulated by 1.39 and 1.45 fold,
respectively. The levels of these two miRNAs by array hybridiza-
tion were found to be 1.42 and 1.41-fold higher in EphB6-
transfected cells as compared to the vector-transfected cells. While
array-hybridization showed 1.55 and 1.46-fold elevations in the
levels of miR-100 and miR-23a, qPCR revealed 1.3 and 1.55-fold
alterations in their levels. These results clearly demonstrate that
the miRNA abundance differences observed by array hybridiza-
tion are comparable to qPCR results.
Target mRNAs for miRNAs and prediction of biologically
relevant mRNAs by using a common target prediction
approach
Given the numerous mRNAs targeted by a single miRNA and
alterations in a large number of miRNAs in a specific condition, it
becomes difficult to identify biologically relevant targets. A
common target prediction approach was used to focus on the
relevancy of miRNAs. Out of the eight miRNAs that were
significantly altered, four miRNAs were selected and their
predicted target mRNA lists compared (http://www.targetscan.
org/). As shown in Table 2, miR-99ab/100 family, miR-23a
family, miR-16 family and miR-24 family have 40, 838, 968 and
438 mRNA targets, respectively. Of the 40 target mRNAs
predicted for miR-99ab/100 family, there were only 9 targets
for miR-100 (Table 2). These 9 targets were compared with the
lists of predicted targets for miR-23a, miR-16 and miR-24. The
comparisons revealed that five miR-100 targets, namely,
SMARCC1, eIF4EBP2, FKB5, TRIB1 and BMPR1B, were
represented in the target lists of other miRNAs. In some cases, the
targets included either isoforms of these mRNAs or mRNAs
involved in related functions. It warrants mention that these genes
represent a small fraction of a combined set of mRNAs targeted by
four miRNAs. Since the target lists for miRNAs include a large
number of mRNAs, we believe that the combinatorial scheme
described above may allow prioritization of target mRNAs for
validation.
Validation of target mRNAs
We selected SMARCC1, eIF2C4, eIF4EBP2, FKABP5,
FKBP1A, TRIB1, TRIB3, BMPR2 and BMPR1A for validation
by PCR. As shown in Figures 5 and 6, the levels of these
transcripts were significantly down-regulated in MDA-MB-231
cells transfected with EphB6. Noteworthy among these targets
Table 1. Altered miRNAs in EphB6-transfected MDA-MB-231
cells.
Upregulated miRs@ Downregulated miRs@
hsa-miR-26a hsa-miRPlus-E1258
hsa-miRPlus-E1172 hsa-miRPlus-E1088
hsa-miR-100 hsa-miRPlus-E1033
hsa-miR-23a hsa-miR-335*
hsa-miR-16 hsa-miRPlus-E1212
hsa-miR-29a hsa-miRPlus-E1117
hsa-miR-24 hsa-miR-32*
hsa-miR-1979 hsa-miR-720
hsa-let-7i hsa-miR-222
hsa-miR-30d hsa-miR-1908
hsa-miR-30a hsa-miR-221
hsa-miR-191 hsa-miR-1285
hsa-miR-30c hsa-miR-183
hsa-miR-34b hsa-miR-665
hsa-miR-130a
hsa-miR-125b
hsa-miR-23b
hsa-miR-30b
hsa-miR-21
hsa-miR-27b
@Array hybridizations were performed with RNA isolated from three
independent clones of vector-transfected and EphB6-transfected DNA as
described in the Methods’ section. The altered RNA at a p-value of ,0.001 are
presented here.
doi:10.1371/journal.pone.0022484.t001
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22484were BMPR2 and eIF4EB2. The mRNAs for BMPR2 and
eIF4EB2 were barely detectable in EphB6 transfected cells. The
levels of SMARCC1, eIF2C4, FKABP5, FKBP1A, TRIB1,
TRIB3 and BMPR1A in the transfected cells were between 20%
and 30% of the native cells. These results validate the rationale for
the selection approach, and clearly demonstrate the low
abundance of a target mRNA for which the relevant miRNA is
up-regulated in the cell. These results clearly demonstrate an
inverse relationship between the levels of miRNAs and their
mRNA targets.
Discussion
Micro RNA profiles have been studied for a number of cancers,
and alterations in a subset of miRNAs have been characterized.
Given the regulatory role played by miRNAs, it is predicted that
these regulatory molecules serve an important function in modula-
ting a variety of processes including tumor initiation, growth and
metastasis. The transfection of EphB6 into MDA-MB-231 cells has
been shown to decrease invasiveness and ability to form foci in soft
agar [5]. These phenotypic changes were subsequently correlated
to altered proteomic profile of EphB6-transfected MDA-MB-231
cells [7]. Such phenotypic changes and altered proteomic profiles
suggested that EphB6 is capable of triggering global molecular
changes, and such a claim is supported by the alterations in
miRNA profiles of EphB6-transfectants described here. Coordi-
nated changes in expression of a family of miRNAs observed in
EphB6-transfected cells indicate organization and regulation of
miRNAs based on their functional significance. The cut-off values
applied for data analysis have allowed the selection of fewer
miRNAs as relevant for the invasive phenotype. Four of these
miRNAs were confirmed by real-time qPCR, which validated the
results of the array platform. Six out of the top eight miRNAs are
involved in a variety of processes and also associated with human
cancers. It has been shown that miR-26a acts via EZH2, an
oncogene markedly elevated in breast cancer cells [14], and affects
Figure 2. Significantly altered miRNAs in EphB6 transfected MDA-MB-231 cells. A. Volcano plot indicating miRNAs with dLMR values
greater than 0.5 or less than 20.5 at a p-value of less than 0.001. The symbols in red color represent the miRNAs meeting the cut-off values. B.
Variations in the values of delta LogMeadianRatio (dLMR) for selected miRNAs are indicated by standard deviations among three replicates.
doi:10.1371/journal.pone.0022484.g002
EphB6 and Micro RNAs
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cells inhibits proliferation [11]. MiR-100 overexpression has been
shown to inhibit mTOR pathway [16]. MiR-23a, which regulates
osteoblast differentiation [17] and is under the control of Myc, is
known to be upregulated in breast cancer [18]. MiR-16, an
inhibitor of Wip1, renders MCF7 cells sensitive to doxorubicin
[19]. MiR-29a antagonizes invasiveness of lung carcinoma cells
[20], and it also leads to epithelial mesenchymal transition (EMT)
and metastasis by suppressing the expression of tristetrapolin [21].
MiR-24 is known to target VEGFR1 (FLT1) and also MMP14
[10], and its under-expression has been observed in 4-OH
tamoxifen-resistant MCF7 cells [22].
A target-based approach is discussed below to extract biological
relevance of changes in abundance of miR-16, miR-23a, miR-24
and miR-100. Although miR-99ab/100 family has 40 targets, only
9 of these targets are assigned to miR-100 in TargetScan (http://
www.targetscan.org/). Thus the numbers of target mRNAs for
miR-100, miR-23a/b, miR-16 family and miR-24 family range
between 9 and 968. Nine mRNA targets of miR-100 were
searched against the targets of miR-16 family, miR-23a/b and
miR-24 family. FKBP5 is a common target of miR-100 and miR-
23a, while SMARCC1 and TRIB1 share functional similarity with
the targets of miR-100. Furthermore, eIF2C4, FKBP1A, TRIB3,
BMPR2 and BMPR1A are other targets that are common
between two of the four miRNAs. The validation of this selection
approach is evident from the observations that each one of the
target mRNAs was down-regulated in cells that over-express its
regulator miRNA. Based on these results, we suggest that the
common-target selection approach described above may help
identify the most likely candidates from the list of in silico predicted
target mRNAs. As discussed below, changes in the abundance of
these transcripts have been shown in a variety of human cancers.
SMARCC1 is altered in prostate and colorectal cancer [23] and
SMARCA5 is known to be dysregulated in leukemia [24] and up-
regulated in human breast tumors [25]. The gene for eIF2C2
maps to a region of gain in breast cancer located at 8q24 [26] and
belongs to the argonaute (AGO) family of genes. Ago2 or eIF2C2
is a core component of the RNA-induced silencing complex
(RISC). The transcripts for eIF2C2 and eIF2C4 and their
corresponding miRNAs are known to be coordinately altered in
breast cancer [27]. A negative regulator of translation, eIF4EBP2,
has been shown to be altered in breast cancer cells upon inhibition
of proteasome [28]. FKBP5 is down-regulated in breast cancer
[29], and its abundance in cancer cells renders them sensitive or
resistant to gemcitabine and AraC. While higher levels of FKBP5
confer sensitivity, low amounts of FKBP5 are associated with
resistance [29]. FKBP12 or FKBP1A has been shown to inhibit
TGFb type 1 receptor [30], and its overexpression has been
reported in astrocytoma [31]. Mammalian homologues of the
Tribles (Trib) family of proteins mediate proteasome-dependent
degradation. These proteins have also been implicated in cancer
phenotypes. Trib1 is involved in the etiology of AML [32] as well
Figure 3. Coordinated changes in the levels of members of
specific miRNA families. The levels of expression for two miRNA
clusters in three vector-transfectants and three EphB6-transfectants are
shown.
doi:10.1371/journal.pone.0022484.g003
Figure 4. Real-time qPCR for significantly altered miRNAs. Total
RNA from two clones of vector-transfected and EphB6-transfected cells
were amplified with specific primers as described in the Methods’
section. Each reaction was carried out in triplicate. The fold-changes in
expression obtained from array hybridization and qPCR are shown.
doi:10.1371/journal.pone.0022484.g004
Table 2. Common or functionally related mRNAs targeted by
four miRNAs*.
miR-100 miR-23a miR-16 miR-24
Target mRNAs:
9
Target mRNAs for
miR-23a/b: 838
Target mRNAs for
miR-16 family: 968
Target mRNAs for
miR-24 family: 438
HS3ST2
SMARCA5 SMARCC1
EPDR1
ZZEF1
EIF2C2 EIF4EB2 EIF2C4
FRAP1
FKBP5 FKBP5 FKBP1A
TRIB2 TRIB1 TRIB3
BMPR2 BMPR1B BMPR1A BMPR2, BMPR1B
*The in silico predictions of target mRNAs were obtained from TargetScan and
miR-100 targets were searched against the lists of targets for miR-23a, miR-16
and miR-24 as described in the Methods’ section.
doi:10.1371/journal.pone.0022484.t002
EphB6 and Micro RNAs
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FOXO in malignant melanoma [34], and Trib3 expression is
altered in colorectal cancer [35]. Although molecular basis of these
changes has not been well-understood, we report here some
involvement of EphB6 in these processes via alterations in the
levels of various miRNAs.
From these data it appears that EphB6 effects may be operative at
two levels. First, its interactions with other proteins may activate
signaling molecules that are responsible for the altered transcription
of their target genes. Second, the products of these target genes are
affecting the transcription of another set of genes. Given the
numerous changes in proteomic profile of EphB6-transfected cells
[7], it is difficult to conclude which miRNAs represent the primary
effects of EphB6. It has been previously shown that several enzymes/
factors involved in general metabolism are altered in EphB6-
transfected cells [7]. The alterations in miR-23a that targets
eIF4EBP2 suggest changes in the rates of protein synthesis and
these changes appear to correlate with the altered proteomic profiles
observed in EphB6-transfected cells [7]. Among the numerous
targets of several miRNAs affected in an EphB6-dependent manner,
interaction of Trib with FOXO assumes cancer related significance.
FOXOproteins,whichbelongtotheforkheadfamilyoftranscription
factors, are regulated by the insulin/PI3K/Akt signaling pathway.
Theseproteinscontrol thetranscription of a varietyofgenes involved
in cell cycle arrest, cell death, DNA repair and energy homeostasis
[36]. Sincethe effects of EphB6 signaling on cell cycle, cell death and
DNA repair have not been studied adequately, the changes in
enzymes involved in bioenergetics pathways in EphB6-transfected
MDA-MB-231 cells [7] suggest that EphB6 may alter energy
homeostasis. MMP14, a target of miR-24, also corroborates our
earlier studies indicating the down-regulation of MMP7 and
MMP19 in EphB6-transfected MDA-MB-231 cells [5].
The alterations in the level of miR-100 assume significance in
the context of PI3K/Akt/mTOR pathway proteins. It is well-
Figure 5. Amplification of mRNAs targeted by various miRNAs. Each panel shows a representative gel picture for the transcript levels in
empty vector-transfected (left lane) and EphB6-transfected (right lane) MDA-MB-231 cells. The bar diagram on the right shows quantification of three
gels for the levels of transcripts. The Y-axis represents arbitrary units of intensity. Empty vector-transfected and EphB6-transfected MDA-MB-231 cells
are designated as 2Eph and +Eph. The transcript designations are indicated in each panel.
doi:10.1371/journal.pone.0022484.g005
EphB6 and Micro RNAs
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variety of cancers, and these pathways are being explored as
targets for therapeutic intervention of cancers [37]. PI3K/Akt
pathway is known to regulate FOXO, which is repressed by Trib2,
a target of miR-100. Thus EphB6 may independently alter the
abundance of target proteins of PI3K/Akt pathway. Secondly, the
linkage between miR-100 overexpression and inhibition of mTOR
pathway [16] supports invasiveness-suppressor effects of EphB6
via mTOR pathway proteins. Similar interpretation may be
forwarded to establish a link between miR-16, EphB6 and the
change in the invasiveness of MDA-MB-231 cells. Mir-16 is
known to be expressed in breast tumor cells, and its elevated levels
in circulation have been related to better prognosis of myelodys-
plastic syndromes [38]. We speculate that the decrease in
invasiveness of EphB6-expressing breast carcinoma cells may be
mediated by miR-16 in a concentration-dependent manner. The
biological significance of these changes may be explained by
associating specific consequences of EphB6 protein with its
abundance as well as the levels of other Eph receptors in breast
carcinoma cells. Our results also suggest that EphB6 may be
exploited as a target for therapeutic intervention of breast cancer
regardless of the specificity of its downstream effects.
The results presented here describe a testable strategy for
confirming biologically relevant targets of various miRNAs. Such
strategies become important because individual miRNAs have
hundreds of target mRNAs, and a large number of miRNAs are
altered when cellular phenotypes change during the natural course
of a disease or following transfection of specific cDNAs. Given that
the specific miRNAs altered in EphB6-transfected cells have been
shown in a variety of cancers and cellular processes, the strategy of
focusing on a set of common mRNAs targeted by two or more
miRNAs assumes significance for their implications on a given
phenotype and underlying mechanisms. Although our data do not
permit us to assign a specific miRNA to EphB6-mediated path-
ways, we suggest that direct and/or indirect downstream effects of
EphB6 signaling may include a variety of miRNAs. These
miRNAs may alter the abundance of proteins involved in cellular
metabolism as well as phenotypes that are hallmarks of breast
Figure 6. Amplification of mRNAs targeted by various miRNAs. Each panel shows a representative gel picture for the transcript levels in
empty vector-transfected (left lane) and EphB6-transfected (right lane) MDA-MB-231 cells. The bar diagram on the right shows quantification of three
gels for the levels of transcripts. The Y-axis represents arbitrary units of intensity. Empty vector-transfected and EphB6-transfected MDA-MB-231 cells
are designated as 2Eph and +Eph. The transcript designations are indicated in each panel. The graph shows linear and comparable amplification of
actin transcript in RNA isolated from empty vector-transfected and EphB6-transfected MDA-MB-231 cells.
doi:10.1371/journal.pone.0022484.g006
EphB6 and Micro RNAs
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concluded that miR-100, miR-23a, miR-16 and miR-24 may act
synergistically to bring about the invasion suppressive phenotype
observed in EphB6-transfected MDA-MB-231 cells.
Materials and Methods
Cell lines and transfections
Breast carcinoma cell line MDA-MB-231 (ATCC, Manassas,
VA, USA) was cultured at 37uC in the presence of 7% CO2 in a
medium containing DMEM (Gibco) with 10% fetal bovine serum
(Hyclone, Logan, UT, USA), 2.0 mM L-glutamine (Gibco),
1.0 mM sodium pyruvate (Gibco), 25 U/ml penicillin (Gibco)
and 25 mg/ml streptomycin (Gibco) [5]. The cells in logarithmic
phase were transfected with either an empty vector or an
expression construct of EphB6 in pCDNA3.1 using Lipofecta-
mine. The transfected cells were grown in the presence of 500 mg/
ml G418 for 2–4 weeks and three surviving clones each of vector
transfected and EphB6 transfected cells, respectively, were
isolated, expanded and stored [5].
RNA isolation and characterization
Thevector-orEphB6-transfectedclonesweregrownasdescribed
above. RNA was isolated from 10 cm tissue culture dishes when
cells were 85–95% confluent using TRIZOL reagent (Invitrogen) as
per the recommended protocol. Briefly, 1 ml of reagent was used
per 10 cm dish followed by the addition of 200 ml chloroform, and
the aqueous phase was separated by centrifugation in a microfuge.
RNA was precipitated by adding 250 ml isopropanol and isolated as
a pellet by centrifugation. The pellet was then washed sequentially
with 80% and 100% ethanol, and air-dried. RNA was dissolved in
DEPC-treated H2O, and stored in aliquots at 280uC.
The concentration of RNA was determined by absorbance
measurements at 260 nm in a nanodrop spectrophotometer.
Contaminating proteins and organic compounds such as phenol in
the RNA preparation were checked by determining absorbance
ratios 260 nm/280 nm and 260 nm/230 nm, respectively. The
quality of RNA was characterized by electrophoresis in Agilent
Bioanalyzer 2100. The electropherogram allowed the quantitation
of 28S rRNA and 18S rRNA as well as the miRNA fraction
separated at 25–30 sec. The appearance of smear or multiple
small peaks in the range between 25 and 50 sec are indicative of
RNA degradation, and these factors were used to calculate the
RNA integrity number [39].
RNA labeling and hybridization to miRNA slides
A common reference sample was made by pooling an aliquot of
each of thxe samples in the experiment. RNA from individual
samples and the common reference pool were labeled with Hy3
TM
and Hy5
TM fluorescent label, respectively, using the miRCUR-
Y
TM LNA Array power labeling kit (Exiqon, Denmark) following
the procedure described by the manufacturer. The Hy3
TM-labeled
samples and a Hy5
TM-labeled reference RNA sample were mixed
pair-wise and hybridized to the miRCURY
TM LNA Array version
5
th Generation (Exiqon, Denmark), which contains capture probes
targeting all miRNAs for human, mouse or rat registered in the
miRBASE version 15.0 at the Sanger Institute. The hybridization
was carried out as recommended by the vendor. After hybridiza-
tion the microarray slides were scanned and the images analyzed.
The analysis of the scanned slides indicated successful labeling of
RNAs as evidenced by the signal intensities of all capture probes
for the control spike-in oligonucleotides. The correlation coeffi-
cients between slides for the spike-in controls for Hy3 as well as
Hy5 channels were near unity. The quantified signals were
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‘locally weighted scatterplot smoothing’ (LOWESS) regression
algorithm. These normalizations were performed to minimize
differences between the colors in an intensity-dependent manner.
Real-time qPCR for validating selected miRNAs
Total RNA (10 ng) was reverse transcribed in triplicates in 10 ml
reactions using the miRCURY LNA
TM Universal RT miRNA
PCR, polyadenylation and cDNA synthesis kit (Exiqon), and the
cDNA was diluted 100-fold. Each PCR was carried out in a total
volume of 10 ml by using 4 ml of the diluted cDNA according to the
miRCURY LNA
TM Universal RT miRNA PCR protocol. The
amplification patterns were used to evaluate melting curves, and Cp
(crossing point) values for each miRNA were determined by
LightCycler 480 software release 1.5.0. The amplification efficien-
cies were calculated by using LinRegPCR [41], and the average
efficiency of each reaction was used to correct the Cp values.
A mixture of RNAs from 20 different tissues was used as a
positive control. Three negative controls consisted of reactions
containing no RNA in the reverse transcription step, no enzyme in
the reverse transcription step and no cDNA in the qPCR step,
respectively. Three miRNAs (miR-let-7a, miR-423-3p and miR-
22) were used as reference. These miRNAs were found to have the
best stability values, as calculated by SLqPCR-R package, and
used to normalize the quantified signal. Based on the geomean Cp
of the reference miRNAs, data were normalized on a well-to-well
basis and DCp values were calculated.
Validation of target mRNAs by PCR
A set of target mRNAs predicted by TargetScan (http://www.
targetscan.org/) was selected for validation. Primers specific to
selected mRNAs (Table 3) were designed and semiquantitative PCR
was performed by using equal amounts of templates corresponding
to empty vector-transfected and EphB6-transfected MDA-MB-231
cells. Total RNA (1.8 mg) was reverse transcribed by using
SuperScript II reverse transcription kit (Invitrogen) as recommended
by the manufacturer. The cDNA was diluted 1:20 and an aliquot
was amplified for 30–40 cycles by using annealing temperatures
specific to various primers. Template concentration was normalized
by amplifying actin transcript. The sequences of primers, annealing
temperatures and amplification cycles are presented in Table 3.
Equal amounts of cDNA made from total RNA of empty
vector-transfected and EphB6-transfected MDA-MB-231 cells
were amplified and an aliquot of the amplified DNA was
electrophoresed in an agarose gel. Each amplification was
performed in triplicate, and the band intensity quantified by using
Quantity One 1-D Analysis Software Version 4.6.5 (BIORAD),
and the results were presented as mean 6 standard deviation.
Author Contributions
Conceived and designed the experiments: RK. Performed the experiments:
LB RK. Analyzed the data: LB RK. Contributed reagents/materials/
analysis tools: LB RK. Wrote the paper: LB RK.
References
1. Kullander K, Klein R (2002) Mechanisms and functions of Eph and ephrin
signalling. Nat Rev Mol Cell Biol 3: 475–486.
2. Pasquale EB (2010) Eph receptors and ephrins in cancer: bidirectional signalling
and beyond. Nat Rev Cancer 10: 165–180.
3. Fox BP, Kandpal RP (2004) Invasiveness of breast carcinoma cells and transcript
profile: Eph receptors and ephrin ligands as molecular markers of potential
diagnostic and prognostic application. Biochem Biophys Res Commun 318:
882–892.
4. Fox BP, Kandpal RP (2006) Transcriptional silencing of EphB6 receptor
tyrosine kinase in invasive breast carcinoma cells and detection of methylated
promoter by methylation specific PCR. Biochem Biophys Res Commun 340:
268–276.
5. Fox BP, Kandpal RP (2009) EphB6 receptor significantly alters invasiveness and
other phenotypic characteristics of human breast carcinoma cells. Oncogene 28:
1706–1713.
6. Fox BP, Kandpal RP (2008) Yeast two- hybrid assay reveals several interactors of
EphB6 receptor. Open Proteomics J 1: 79–86.
7. Kandpal RP (2010) Tyrosine kinase-deficient EphB6 receptor-dependent
alterations in proteomic profiles of invasive breast carcinoma cells as determined
by difference gel electrophoresis. Cancer Genomics Proteomics 7: 253–260.
8. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-
transcriptional regulation by microRNAs: are the answers in sight? Nat Rev
Genet 9: 102–114.
9. Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA
networks: the implications for cancer research. Nat Rev Cancer 10: 389–402.
10. Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer.
Oncogene 25: 6170–6175.
11. Kota J, Chivukula RR, O’Donnell KA, Wentzel EA, Montgomery CL, et al.
(2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine
liver cancer model. Cell 137: 1005–1017.
12. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in
cancer. Nat Rev Cancer 6: 259–269.
13. Song G, Sharma AD, Roll GR, Ng R, Lee AY, et al. (2010) MicroRNAs control
hepatocyte proliferation during liver regeneration. Hepatology 51: 1735–1743.
14. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, et al. (2003) EZH2 is a marker
of aggressive breast cancer and promotes neoplastic transformation of breast
epithelial cells. Proc Natl Acad Sci U S A 100: 11606–11611.
15. Lu J, He ML, Wang L, Chen Y, Liu X, et al. (2011) MiR-26a inhibits cell
growth and tumorigenesis of nasopharyngeal carcinoma through repression of
EZH2. Cancer Res 71: 225–233.
16. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, et al. (2010) A link
between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol
Endocrinol 24: 447–463.
17. Hassan MQ, Gordon JA, Beloti MM, Croce CM, van Wijnen AJ, et al. (2010) A
network connecting Runx2, SATB2, and the miR-23a,27a,24-2 cluster
regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 107:
19879–19884.
18. Chhabra R, Dubey R, Saini N (2010) Cooperative and individualistic functions
of the microRNAs in the miR-23a,27a,24-2 cluster and its implication in
human diseases. Mol Cancer 9: 232.
19. Zhang X, Wan G, Mlotshwa S, Vance V, Berger FG, et al. (2010) Oncogenic
Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling
pathway. Cancer Res 70: 7176–7186.
20. Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, et al. (2009)
MiRNA-29a regulates the expression of numerous proteins and reduces the
invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer 45:
3104–3118.
21. Gebeshuber CA, Zatloukal K, Martinez J (2009) miR-29a suppresses
tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO
Rep 10: 400–405.
22. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, et al. (2008) MicroRNA-
221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.
J Biol Chem 283: 29897–29903.
23. Andersen CL, Christensen LL, Thorsen K, Schepeler T, Sorensen FB, et al.
(2009) Dysregulation of the transcription factors SOX4, CBFB and SMARCC1
correlates with outcome of colorectal cancer. Br J Cancer 100: 511–523.
24. Stopka T, Zakova D, Fuchs O, Kubrova O, Blafkova J, et al. (2000) Chromatin
remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of
acute leukemia. Leukemia 14: 1247–1252.
25. Klein A, Wessel R, Graessmann M, Jurgens M, Petersen I, et al. (2007)
Comparison of gene expression data from human and mouse breast cancers:
identification of a conserved breast tumor gene set. Int J Cancer 121: 683–688.
26. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, et al. (2005) High
resolution genomic analysis of sporadic breast cancer using array-based
comparative genomic hybridization. Breast Cancer Res 7: R1186–1198.
27. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. (2007)
MicroRNA expression profiling of human breast cancer identifies new markers
of tumor subtype. Genome Biol 8: R214.
28. Kinyamu HK, Collins JB, Grissom SF, Hebbar PB, Archer TK (2008) Genome
wide transcriptional profiling in breast cancer cells reveals distinct changes in
hormone receptor target genes and chromatin modifying enzymes after
proteasome inhibition. Mol Carcinog 47: 845–885.
29. Li L, Lou Z, Wang L (2011) The role of FKBP5 in cancer aetiology and
chemoresistance. Br J Cancer 104: 19–23.
30. Okadome T, Oeda E, Saitoh M, Ichijo H, Moses HL, et al. (1996)
Characterization of the interaction of FKBP12 with the transforming growth
factor-beta type I receptor in vivo. J Biol Chem 271: 21687–21690.
31. Khatua S, Peterson KM, Brown KM, Lawlor C, Santi MR, et al. (2003)
Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in
EphB6 and Micro RNAs
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22484childhood astrocytomas by angiogenesis gene profiling. Cancer Res 63:
1865–1870.
32. Jin G, Yamazaki Y, Takuwa M, Takahara T, Kaneko K, et al. (2007) Trib1 and
Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood 109:
3998–4005.
33. Puiffe ML, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, et al. (2007)
Characterization of ovarian cancer ascites on cell invasion, proliferation,
spheroid formation, and gene expression in an in vitro model of epithelial
ovarian cancer. Neoplasia 9: 820–829.
34. Zanella F, Renner O, Garcia B, Callejas S, Dopazo A, et al. (2010) Human
TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of
melanoma cells. Oncogene 29: 2973–2982.
35. Miyoshi N, Ishii H, Mimori K, Takatsuno Y, Kim H, et al. (2009) Abnormal
expression of TRIB3 in colorectal cancer: a novel marker for prognosis.
Br J Cancer 101: 1664–1670.
36. Greer EL, Brunet A (2005) FOXO transcription factors at the interface between
longevity and tumor suppression. Oncogene 24: 7410–7425.
37. Ghayad SE, Cohen PA (2010) Inhibitors of the PI3K/Akt/mTOR pathway:
new hope for breast cancer patients. Recent Pat Anticancer Drug Discov 5:
29–57.
38. Zuo Z, Calin GA, de Paula HM, Medeiros LJ, Fernandez MH, et al. (2011)
Circulating microRNAs let-7a and miR-16 predict progression-free survival and
overall survival in patients with myelodysplastic syndrome. Blood;doi:10.1182/
blood-2011-01-330704.
39. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The
RIN: an RNA integrity number for assigning integrity values to RNA
measurements. BMC Mol Biol 7: 3.
40. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, et al. (2007) A
comparison of background correction methods for two-colour microarrays.
Bioinformatics 23: 2700–2707.
41. Ramakers C, Ruijter JM, Deprez RH, Moorman AF (2003) Assumption-free
analysis of quantitative real-time polymerase chain reaction (PCR) data.
Neurosci Lett 339: 62–66.
EphB6 and Micro RNAs
PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22484